Vaccinations for Children & Adults

Call on : 022-6757-0111


Click on brochures
Immunization for Children
Immunization for Adults

Important Instructions:


  • NO VACCINE IS 100 % EFFECTIVE; PLEASE CHECK THE EFFICACY OF INDIVDUAL VACCINES BEFORE IMMUNIZATION.

  • MINOR UPPER RESPIRATORY INFECTIONS ARE NO CONTRAINDICATIONS OF IMMUNIZATIONS.

  • TWO LIVE VACCINES SHOULD BE GIVEN EITHER SIMULTANEOUSLY AT DIFFERENT SITE AT THE SAME SITTING OR AT LEAST ONE MONTH APART.

  • VACCINATION SCHEDULES DIFFER IN DIFFERENT COUNTRIES ACCORDING TO THEIR NEEDS.

  • PULSE POLIO VACCINATIONS / OTHER IMMUNIZATIONS ON NATIONAL IMMUNIZATION DAYS ARE DIFFERENT FROM ROUTINE VACCINATIONS AND SHOULD BE FOLLOWED AS PER THE INSTRUCTIONS IN THE NATIONAL INTEREST.

  • FOLLOW POST VACCINATION INSTRUCTIONS AS ADVISED, AND REPORT ADVERSE REACTIONS IF ANY, IMMEDIATELY.

About Vaccinations
  • Over the past few years, Immunization has prevented approximately 20 million deaths from vaccine-preventable infections.
  • Saifee Hospital ensure vaccine effectiveness, efficiency, safety, and storage and organize immunization programs to save even more lives.
  • Immunization is a valuable tool for protecting health, enhancing and saving lives.

Immunization Timetable
I. IAP recommended vaccines for routine use
Age Vaccines Comments
1 AT BIRTH BCG
OPV 0
Hep-B 1
Administer these vaccines to all newborns before hospital discharge
2 6 WEEKS DTwP 1
IPV 1
Hep-B 2
Hib-1
Rotavirus-1
PCV-1
DTP:
  • DTaP vaccine/combinations should preferably be avoided for the primary series
  • DTaP vaccine/combinations should be preferred in certain specific circumstances/conditions only
  • No need of repeating/giving additional doses of wholecell pertussis (wP) vaccine to a child who has earlier completed their primary schedule with acellular pertussis (aP) vaccine-containing products
Polio:
  • All doses of IPV may be replaced with OPV if administration of the former is unfeasible
  • Additional doses of OPV on all supplementary immunization activities (SIAs)
  • Two doses of IPV instead of 3 for primary series if started at 8 weeks, and 8 weeks interval between the doses
  • No child should leave the facility without polio immunization (IPV or OPV), if indicated by the schedule
See footnotes under figure titled IAP recommended immunization schedule (with range) for recommendations on intradermal IPV

Rotavirus:
  • 2 doses of RV1 and 3 doses of RV5 & RV 116E
  • RV1 should be employed in 10 & 14 week schedule, 10 & 14 week schedule of RV1 is found to be more immunogenic than 6 & 10 week schedule
3 10 WEEKS DTwP-2
IPV-2
Hib-2
Rotavirus-2
PCV-2
Rotavirus:
If RV1 is chosen, the first dose should be given at 10 weeks
4 14 WEEKS DTwP-3
IPV-3
Hib-3
Rotavirus-3
PCV-3
Rotavirus:
  • Only 2 doses of RV1 are recommended.
  • If RV1 is chosen, the 2nd dose should be given at 14 weeks
5 6 MONTHS OPV-1
Hep-B-3
Hepatitis-B:
The final (3rd or 4th ) dose in the HepB vaccine series should be administered no earlier than age 24 weeks and at least 16 weeks after the first dose.
6 9 MONTHS OPV-2
MMR-1
MMR:
  • Measles-containing vaccine ideally should not be administered before completing 270 days or 9 months of life
  • The 2nd dose must follow in 2nd year of life
  • No need to give stand-alone measles vaccine
7 9-12 MONTHS Typhoid Conjugate Vaccine
  • Currently, two typhoid conjugate vaccines, Typbar-TCV® and PedaTyph® available in Indian market; either can be used
  • An interval of at least 4 weeks with the MMR vaccine should be maintained while administering this vaccine
8 12 MONTHS Hep-A-1 Hepatitis A:
  • Single dose for live attenuated H2-strain Hep-A vaccine
  • Two doses for all inactivated Hep-A vaccines are recommended
9 15 MONTHS MMR-2
Varicella-1
PCV-booster
MMR:
  • The 2nd dose must follow in 2nd year of life
  • However, it can be given at anytime 4-8 weeks after the 1st dose
Varicella:
The risk of breakthrough varicella is lower if given 15 months onwards
10 16-18 MONTHS DTwP-B1/DTaP-B1
IPV-B1
Hib-B1
The first booster (4thth dose) may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose. DTP:
  • 1st & 2nd boosters should preferably be of DTwP
  • Considering a higher reactogenicity of DTwP, DTaP can be considered for the boosters
11 18 MONTHS Hep-A-2 Hepatitis A: 2nd dose for inactivated vaccines only
12 2 YEARS Booster of Typhoid
Conjugate Vaccine
  • A booster dose of Typhoid conjugate vaccine (TCV), if primary dose is given at 9-12 months
  • A dose of Typhoid Vi-polysaccharide (Vi-PS) vaccine can be given if conjugate vaccine is not available or feasible
  • Revaccination every 3 years with Vi-polysaccharide vaccine
  • Typhoid conjugate vaccine should be preferred over Vi- PS vaccine
13 4-6 YEARS DTwP-B2/DTaP-B2
OPV-3
Varicella-2
MMR 3
Varicella: The 2nd dose can be given at anytime 3 months after the 1st dose.

MMR: The 3rd dose is recommended at 4-6 years of age.
14 10-12 YEARS Tdap/Td
HPV
Tdap: is preferred to Td followed by Td every 10 years

HPV:
  • Only 2 doses of either of the two HPV vaccines for adolescent/preadolescent girls aged 9-14 years;
  • For girls 15 years and older and immunocompromised individuals, 3 doses are recommended
  • For two-dose schedule, the minimum interval between doses should be 6 months.
  • For 3 dose schedule, the doses can be administered at 0, 1-2 (depending on brand) and 6 months
II. IAP recommended vaccines for High-risk children (Vaccines under special circumstances):
  1. Influenza Vaccine
  2. Meningococcal Vaccine
  3. Japanese Encephalitis Vaccine
  4. Cholera Vaccine
  5. Rabies Vaccine
  6. Yellow Fever Vaccine
  7. Pneumococcal Polysaccharide vaccine (PPSV 23)
High-risk category of children:
  • Congenital or acquired immunodeficiency (including HIV infection), Chronic cardiac, pulmonary (including asthma if treated with prolonged high-dose oral corticosteroids), hematologic, renal (including nephrotic syndrome), liver disease and diabetes mellitus
  • Children on long term steroids, salicylates, immunosuppressive or radiation therapy
  • Diabetes mellitus, Cerebrospinal fluid leak, Cochlear implant, Malignancies,
  • Children with functional/ anatomic asplenia/ hyposplenia
  • During disease outbreaks
  • Laboratory personnel and healthcare workers
  • Travelers
  • Children having pets in home
  • Children perceived with higher threat of being bitten by dogs such as hostellers, risk of stray dog menace while going outdoor.

Pediatrics & Neonatology